The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters

Prostate Cancer Clinical Trial

Official title:

The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05399940
• Other study ID #: 22/5-27
• Status: Completed
• Start date: January 1, 2018
• Est. completion date: May 20, 2022

Study information

• Verified date: May 2022
• Source: Hisar Intercontinental Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Purpose:

To find the correlation between hemogram parameters and Delta Neutrophil Index(DNI) and Serum PSA in patients presenting with the diagnosis of acute prostatitis.

Material-Metod: Serum PSA levels and hemogram parameters of patients who came to the urology outpatient clinic in January 2018 and May 2022 and were diagnosed with prostatitis were collected retrospectively.

Description:

Serum PSA levels and hemogram parameters of patients who came to the urology outpatient clinic in January 2018 and May 2022 and were diagnosed with prostatitis were collected retrospectively.

WBC, neutrophil, lymphocyte, neutrophil-lymphocyte ratio, delta neutrophil index (DNI), PLT, RDW, and MPV values were determined in the Hemogram Parameters. Serum Total PSA and Free PSA values of the patients were also checked. Urine culture, urinary ultrasound, and antibiotic therapy

Recruitment information / eligibility

• Status: Completed
• Enrollment: 250
• Est. completion date: May 20, 2022
• Est. primary completion date: May 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

Acute prostatitis Male

-

Exclusion Criteria:

Prostate cancer Chronic prostatitis Other Urinary infections,

-

Related Conditions & MeSH terms

• Prostate Cancer
• Prostate Disease
• Prostate Infection
• Prostatic Diseases

Intervention

Diagnostic Test:
• Serum PSA,Delta Neutrophil Index(DNI),WBC
Urine culture, prostate volume

Locations

Country	Name	City	State
Turkey	Basri Cakiroglu	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Hisar Intercontinental Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Area Under the Plasma Concentration Versus Time Curve (AUC)		4 years